ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P13
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-12.11%
Q3 202518.93%
Q2 2025-4.23%
Q1 2025-6.79%
Q4 202461.37%
Q3 2024-1.97%
Q2 2024-2.47%
Q1 2024-2.40%
Q4 2023-6.18%
Q3 2023-3.94%
Q2 2023-4.59%
Q1 2023-3.64%
Q4 2022608.33%
Q3 2022-13.72%
Q2 2022-85.26%
Q1 2022408.53%
Q4 2021-82.57%
Q3 2021-3.93%
Q2 2021-3.98%
Q1 2021-3.19%
Q4 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%